Editorial
doi: 10.1001/jamaoncol.2021.1516.
Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?
Affiliations
- PMID: 34165515
- DOI: 10.1001/jamaoncol.2021.1516
Item in Clipboard
Editorial
Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?
JAMA Oncol.
.
No abstract available
Comment on
-
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial.JAMA Oncol. 2021 Aug 1;7(8):1149-1157. doi: 10.1001/jamaoncol.2021.1854. JAMA Oncol. 2021. PMID: 34165508 Free PMC article. Clinical Trial.
Similar articles
-
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).J Clin Oncol. 2013 Jul 20;31(21):2685-91. doi: 10.1200/JCO.2012.46.4792. Epub 2013 Jun 24. J Clin Oncol. 2013. PMID: 23796998 Clinical Trial.
-
Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer.JAMA Oncol. 2022 Jan 1;8(1):171. doi: 10.1001/jamaoncol.2021.5765. JAMA Oncol. 2022. PMID: 34792535 No abstract available.
-
Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer-Reply.JAMA Oncol. 2022 Jan 1;8(1):171-172. doi: 10.1001/jamaoncol.2021.5768. JAMA Oncol. 2022. PMID: 34792528 No abstract available.
-
Efficacy and acceptability of neoadjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: A network meta-analysis.J Cell Physiol. 2019 Aug;234(8):12393-12403. doi: 10.1002/jcp.28068. Epub 2019 Jan 16. J Cell Physiol. 2019. PMID: 30652307 Review.
-
Ultrashort courses of adjuvant breast radiotherapy: wave of the future or a fool's errand?Cancer. 2012 Apr 15;118(8):1962-70. doi: 10.1002/cncr.26457. Epub 2011 Aug 26. Cancer. 2012. PMID: 22009259 Review.
Cited by
-
Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.Cancer Control. 2024 Jan-Dec;31:10732748241288118. doi: 10.1177/10732748241288118. Cancer Control. 2024. PMID: 39340434 Free PMC article.
-
Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis.Cochrane Database Syst Rev. 2024 Jul 9;7(7):CD013451. doi: 10.1002/14651858.CD013451.pub2. Cochrane Database Syst Rev. 2024. PMID: 38979716 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
